According to the New York Times, the first doses of the Janssen vaccine by Johnson & Johnson arrived in Italy while in the US, according to the New York Times, discontinuation of use was required. The Food and Drug Administration and the Centers for Disease Control will discontinue use of the vaccine in federal sites and will urge states to conduct pending investigations of these issues. safety problem. The suspension has been linked to six cases in the United States who developed a rare disease involving a blood clot in the two weeks following vaccination.
All six rare cases have involved women between the ages of 18 and 48, NYT writes, citing officials who reported the case. One of them died while a second, in Nebraska, was hospitalized in critical condition. To date, about seven million people in the United States have been vaccinated against Johnson & Johnson. The Food and Drug Administration announced on Twitter: “We recommend that this vaccine be discontinued with caution. At 10 a.m. US time (4 p.m. Italian time), a press conference on the affair was announced.
The number of doses Johnson & Johnson will arrive in the afternoon at the Pratica di Mare Defense Center is 184 thousand and this is the first batch of US vaccines to arrive in Italy. These doses, along with about 175,000 Vaxzevria (AstraZeneca, ed) vaccines that are part of the 4.2 million doses, will arrive in Italy between 15-22 April to be made available to the Regions.
Still on the topic of vaccines, meanwhile, India has approved the Russian use of Sputnik. According to online Guardian. “India, the second most populous country in the world, became the 60th country to register for SputnikV after the positive results of the phase 3 clinical trial. The Russian vaccine is now authorized in 60 countries. with a population of more than 3 billion people “
ABOUT US RESERVED © Copyright ANSA